2025 HCPCS Code Q2054
Lisocabtagene maraleucel, up to 110 million autologous anti-cd19 car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
TAGS: lisocabtagene viable preparation leukapheresis autologous therapeutic millionShort Description | Lisocabtagene mara car pos t |
HCPCS Action Code | N - No maintenance for this code |
HCPCS Coverage Code | C - Carrier judgment |
HCPCS Code Added Date | October 01, 2021 |
HCPCS Action Effective Date | October 01, 2021 |
HCPCS Pricing Indicator Code | 51 - Drugs |
HCPCS Type Of Service Code | 1 - Medical care |
HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
HCPCS Anesthesia Base Unit Quantity | 0 |
HCPCS Coverage Issues Manual Reference Section Number |
Check Similar HCPCS Codes
- Q4195 - Puraply 1 sq cm
- Q4196 - Puraply am 1 sq cm
- Q4197 - Puraply xt 1 sq cm
- Q4198 - Genesis amnio membrane 1sqcm
- Q4199 - Cygnus matrix, per sq cm
- Q4200 - Skin te 1 sq cm
- Q4201 - Matrion 1 sq cm
- Q4202 - Keroxx (2.5g/cc), 1cc
- Q4203 - Derma-gide, 1 sq cm
- Q4204 - Xwrap 1 sq cm
- Q4205 - Membrane graft or wrap sq cm
- Q4206 - Fluid flow or fluid gf 1 cc
- Q4208 - Novafix per sq cm
- Q4209 - Surgraft per sq cm
- Q4210 - Axolotl graf dualgraf sq cm
- Q4211 - Amnion bio or axobio sq cm
- Q4212 - Allogen, per cc
- Q4213 - Ascent, 0.5 mg
- Q4214 - Cellesta cord per sq cm
- Q4215 - Axolotl ambient, cryo 0.1 mg